(RS)-bromo-dragonfly
Bromo-DragonFLY, also known as DOB-DragonFLY (DOB-DFLY), is a psychedelic drug of the phenethylamine, DOx, and FLY families. It is taken orally. The drug has a delayed onset of up to 6hours and a very long duration of up to 1 to 3days.
Key facts
- Drug.Verifiedfields
- verified
- Drug.Watchedfields
- verified
- Drug.verifiedrevid
- 459828654
- Drug.image
- Bromo-DragonFLY.svg
- Drug.image_class
- skin-invert-image
- Drug.width
- 225px
- Drug.image2
- Bromo-DragonFLY ball-and-stick structure.png
- Drug.image_class2
- bg-transparent
- Drug.width2
- 205px
- Drug.routes_of_administration
- Oral
- Drug.class
- Serotonin 5-HT2 receptor agonist; Serotonin 5-HT2A receptor agonist; Serotonergic psychedelic; Hallucinogen; Monoamine oxidase inhibitor (MAOI); Reversible inhibitor of monoamine oxidase A (RIMA)
- Drug.ATC_prefix
Article
26 sectionsContents
- Use and effects
- Side effects
- Overdose and toxicity
- Interactions
- Pharmacology
- Pharmacodynamics
- Pharmacokinetics
- Chemistry
- Synthesis
- Analogues
- History
- Society and culture
- Legal status
- Australia
- Canada
- Denmark
- Finland
- Norway
- Poland
- Romania
- Sweden
- United Kingdom
- United States
- See also
- References
- External links
Bromo-DragonFLY, also known as DOB-DragonFLY (DOB-DFLY), is a psychedelic drug of the phenethylamine, DOx, and FLY families. It is taken orally. The drug has a delayed onset of up to 6hours and a very long duration of up to 1 to 3days.
Side effects of Bromo-DragonFLY include nausea and vomiting, headache, tachycardia, hypertension, anxiety, panic attacks, pupil dilation, convulsions and vasoconstriction, among others. The drug acts as an agonist of the serotonin 5-HT2 receptors, including the serotonin 5-HT2A, 5-HT2B, and 5-HT2C receptors. It is also a potent monoamine oxidase A (MAO-A) inhibitor.